CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $0 | – | 26,210 | +7120.4% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 363 | -86.3% | 0.00% | – |
Q4 2019 | $42,000 | +4100.0% | 2,644 | +2570.7% | 0.00% | – |
Q3 2019 | $1,000 | -96.4% | 99 | -94.2% | 0.00% | – |
Q2 2019 | $28,000 | -56.9% | 1,704 | -55.2% | 0.00% | – |
Q1 2019 | $65,000 | +18.2% | 3,803 | +21.7% | 0.00% | – |
Q4 2018 | $55,000 | +685.7% | 3,125 | +656.7% | 0.00% | – |
Q3 2018 | $7,000 | +40.0% | 413 | +56.4% | 0.00% | – |
Q2 2018 | $5,000 | -85.7% | 264 | -86.9% | 0.00% | -100.0% |
Q1 2018 | $35,000 | +29.6% | 2,022 | -17.4% | 0.00% | +100.0% |
Q4 2017 | $27,000 | – | 2,448 | +8966.7% | 0.00% | – |
Q3 2015 | $0 | – | 27 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
S. MUOIO & CO. LLC | 52,468 | $964,000 | 1.05% |
Olympiad Research LP | 54,795 | $1,007,000 | 0.58% |
Alpine Global Management, LLC | 119,902 | $2,204,000 | 0.45% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 65,922 | $1,212,000 | 0.19% |
First Trust Capital Management L.P. | 32,688 | $601,000 | 0.17% |
GLAZER CAPITAL, LLC | 232,103 | $4,266,000 | 0.15% |
Walleye Capital LLC | 105,000 | $1,930,000 | 0.13% |
Yakira Capital Management, Inc. | 17,588 | $323,000 | 0.08% |
Dynamic Technology Lab Private Ltd | 17,929 | $330,000 | 0.05% |
EQUITEC PROPRIETARY MARKETS, LLC | 10,600 | $195,000 | 0.05% |